IGF1R and central nervous system cancer: MiR-323-5p can reportedly act as a tumour suppressor in human glioma cells by targeting the insulin-like growth factor 1 receptor, can inhibit cell proliferation by blocking IGF-1R-mediated migration [41]; however; its role in ageing-related angiogenesis has not been reported.